hotspot -WSS

hotspot

author：hotspot 2025-10-02 06:02:30 - browse：86

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Focused ultrasound for uterine fibroids: an uphill battle

WSS

Biohaven protein

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

White House touts steps to stem shortages of cancer treatments

Addiction doctors spar with methadone clinics over legislation

Heat waves linked to early deliveries, preterm births in new study

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

focus

hotspot

hotspot

Heart attack and stroke risk calculators need revising

How medical schools plan to diversify without affirmative action

Malaria cases in Florida and Texas: Here’s what you need to know

Akili, maker of video game for ADHD, to be acquired for 34 million

In age of alternative facts, a scholarly course on calling out crap

Prosthetic arm enables patients to feel the objects they grip

Virginia high school admissions case could be legal follow

A common UTI test for kids haunts adults as a traumatic 'nightmare'

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Hospitals consider fixing cancer drug shortages on their own

hotspot

Dark money group runs ads on China biotech bill

Insmed lung disease drug hits target in key Phase 3 trial

Popular nasal decongestant doesn't actually relieve congestion

Biohaven protein

Prosthetic arm enables patients to feel the objects they grip

Heat waves linked to early deliveries, preterm births in new study

Wikipedia

entertainment

focus

focus